{"id":49655,"date":"2026-04-16T01:56:32","date_gmt":"2026-04-16T01:56:32","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/49655\/"},"modified":"2026-04-16T01:56:32","modified_gmt":"2026-04-16T01:56:32","slug":"ubs-adjusts-pharma-outlook-increases-pfizer-pfe-price-target-2","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/49655\/","title":{"rendered":"UBS Adjusts Pharma Outlook, Increases Pfizer (PFE) Price Target"},"content":{"rendered":"\n<p class=\"yf-1fy9kyt\">Pfizer Inc. (NYSE:<a href=\"https:\/\/finance.yahoo.com\/quote\/PFE\" data-ylk=\"slk:PFE;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;PFE&quot;}\" class=\"link \" rel=\"nofollow noopener\" target=\"_blank\">PFE<\/a>) is included among the <a href=\"https:\/\/www.insidermonkey.com\/blog\/14-value-stocks-with-highest-dividends-1737584\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:14 Value Stocks with Highest Dividends;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;14 Value Stocks with Highest Dividends&quot;}\" class=\"link \">14 Value Stocks with Highest Dividends<\/a>.<\/p>\n<p>    <img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/04\/aef4b35e5ea946bf7f4ed347e5c4f487.jpeg\" alt=\"UBS Adjusts Pharma Outlook, Increases Pfizer (PFE) Price Target\" loading=\"eager\" height=\"538\" width=\"960\" class=\"yf-lglytj  loaded\"\/> UBS Adjusts Pharma Outlook, Increases Pfizer (PFE) Price Target      <\/p>\n<p class=\"yf-1fy9kyt\">On April 13, UBS Group AG raised its price recommendation on Pfizer Inc. (NYSE:PFE) to $27 from $25. It maintained a Neutral rating on the shares. The update came as part of the firm\u2019s Q1 preview for the pharmaceuticals and biotechnology group, where it adjusted its targets.<\/p>\n<p class=\"yf-1fy9kyt\">During its Q4 2025 earnings call, Pfizer stuck with its 2026 outlook. It expects revenue to land between $59.5 billion and $62.5 billion. Adjusted diluted EPS is still projected in the range of $2.80 to $3.00 for the year. CFO David Denton said COVID-related products will decline further in 2026, with revenue expected at around $5 billion. He noted that the non-COVID portfolio should hold steady, though it includes an estimated $1.5 billion headwind from products facing generic competition.<\/p>\n<p class=\"yf-1fy9kyt\">He added that, at the midpoint of guidance, revenue excluding COVID products and those impacted by loss of exclusivity is expected to grow roughly 4% on an operational basis compared to last year. Management also said it is aiming for the first in a series of potential approvals for its obesity portfolio starting in 2028.<\/p>\n<p class=\"yf-1fy9kyt\">Pfizer Inc. (NYSE:PFE) is a research-based global biopharmaceutical company. It focuses on the discovery, development, manufacturing, marketing, sale, and distribution of biopharmaceutical products worldwide.<\/p>\n<p class=\"yf-1fy9kyt\">While we acknowledge the potential of PFE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you&#8217;re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the<a class=\"link \" href=\"https:\/\/www.insidermonkey.com\/blog\/three-megatrends-one-overlooked-stock-massive-upside-1548959\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:\u00a0best short-term AI stock;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;&amp;nbsp&quot;}\">\u00a0best short-term AI stock<\/a>.<\/p>\n<p class=\"yf-1fy9kyt\">READ NEXT:\u00a0<a href=\"https:\/\/www.insidermonkey.com\/blog\/13-nasdaq-stocks-with-highest-dividends-1736918\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:13 NASDAQ Stocks with Highest Dividends;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;13 NASDAQ Stocks with Highest Dividends&quot;}\" class=\"link \">13 NASDAQ Stocks with Highest Dividends<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.insidermonkey.com\/blog\/15-cash-rich-dividend-stocks-to-invest-in-right-now-1736994\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:15 Cash-Rich Dividend Stocks to Invest In Right Now;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;15 Cash-Rich Dividend Stocks to Invest In Right Now&quot;}\" class=\"link \">15 Cash-Rich Dividend Stocks to Invest In Right Now<\/a><\/p>\n<p class=\"yf-1fy9kyt\">Disclosure: None. <a href=\"https:\/\/news.google.com\/publications\/CAAqLQgKIidDQklTRndnTWFoTUtFV2x1YzJsa1pYSnRiMjVyWlhrdVkyOXRLQUFQAQ?hl=en-US&amp;gl=US&amp;ceid=US%3Aen\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Follow Insider Monkey on Google News;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Follow Insider Monkey on Google News&quot;}\" class=\"link \">Follow Insider Monkey on Google News<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"Pfizer Inc. (NYSE:PFE) is included among the 14 Value Stocks with Highest Dividends. UBS Adjusts Pharma Outlook, Increases&hellip;\n","protected":false},"author":2,"featured_media":49656,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[129],"tags":[2349,223,880],"class_list":{"0":"post-49655","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-ubs","8":"tag-pfizer-inc","9":"tag-ubs","10":"tag-ubs-group-ag"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116411903747480382","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/49655","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=49655"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/49655\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/49656"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=49655"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=49655"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=49655"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}